Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Optimal dosing for psilocybin pharmacotherapy: Considering weight-adjusted and fixed dosing approaches
Albert Garcia‐Romeu, Frederick S. Barrett, Theresa M. Carbonaro, et al.
Journal of Psychopharmacology (2021) Vol. 35, Iss. 4, pp. 353-361
Open Access | Times Cited: 72

Showing 1-25 of 72 citing articles:

The Therapeutic Potential of Psilocybin
Henry Lowe, Ngeh J. Toyang, Blair Steele, et al.
Molecules (2021) Vol. 26, Iss. 10, pp. 2948-2948
Open Access | Times Cited: 156
Direct comparison of the acute effects of lysergic acid diethylamide and psilocybin in a double-blind placebo-controlled study in healthy subjects
Friederike Holze, Laura Ley, Felix Müller, et al.
Neuropsychopharmacology (2022) Vol. 47, Iss. 6, pp. 1180-1187
Open Access | Times Cited: 148
Acute Effects of Psilocybin After Escitalopram or Placebo Pretreatment in a Randomized, Double‐Blind, Placebo‐Controlled, Crossover Study in Healthy Subjects
A. Becker, Friederike Holze, Tanja Grandinetti, et al.
Clinical Pharmacology & Therapeutics (2021) Vol. 111, Iss. 4, pp. 886-895
Open Access | Times Cited: 131
Microdosing with psilocybin mushrooms: a double-blind placebo-controlled study
Federico Cavanna, Stephanie Müller, Laura Alethia de la Fuente, et al.
Translational Psychiatry (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 78
Psychedelic resting-state neuroimaging: A review and perspective on balancing replication and novel analyses
Drummond E-Wen McCulloch, Gitte M. Knudsen, Frederick S. Barrett, et al.
Neuroscience & Biobehavioral Reviews (2022) Vol. 138, pp. 104689-104689
Open Access | Times Cited: 77
Therapeutic effect of psilocybin in addiction: A systematic review
Pim B. van der Meer, Juan José Fuentes, Ad A. Kaptein, et al.
Frontiers in Psychiatry (2023) Vol. 14
Open Access | Times Cited: 72
Naturalistic psilocybin use is associated with persisting improvements in mental health and wellbeing: results from a prospective, longitudinal survey
Sandeep M. Nayak, Hillary Jackson, Nathan D. Sepeda, et al.
Frontiers in Psychiatry (2023) Vol. 14
Open Access | Times Cited: 44
Assessing the risk–benefit profile of classical psychedelics: a clinical review of second-wave psychedelic research
David A. Bender, David J. Hellerstein
Psychopharmacology (2022) Vol. 239, Iss. 6, pp. 1907-1932
Closed Access | Times Cited: 64
Pharmacokinetics and Pharmacodynamics of Oral Psilocybin Administration in Healthy Participants
Friederike Holze, A. Becker, Karolina E. Kolaczynska, et al.
Clinical Pharmacology & Therapeutics (2022) Vol. 113, Iss. 4, pp. 822-831
Open Access | Times Cited: 60
Whitewashing psychedelics: racial equity in the emerging field of psychedelic-assisted mental health research and treatment
Johannes Thrul, Albert Garcia‐Romeu
Drugs Education Prevention and Policy (2021) Vol. 28, Iss. 3, pp. 211-214
Open Access | Times Cited: 58
Neural Mechanisms and Psychology of Psychedelic Ego Dissolution
Devon Stoliker, Gary F. Egan, Karl Friston, et al.
Pharmacological Reviews (2022) Vol. 74, Iss. 4, pp. 876-917
Open Access | Times Cited: 54
Therapeutic use of psilocybin: Practical considerations for dosing and administration
Caroline A. MacCallum, Lindsay A. Lo, Carly A. Pistawka, et al.
Frontiers in Psychiatry (2022) Vol. 13
Open Access | Times Cited: 46
Pharmacokinetics of N,N-dimethyltryptamine in Humans
Meghan Good, Zelah Joel, Tiffanie Benway, et al.
European Journal of Drug Metabolism and Pharmacokinetics (2023) Vol. 48, Iss. 3, pp. 311-327
Open Access | Times Cited: 30
Psilocybin: From Psychiatric Pariah to Perceived Panacea
Gregory A. Fonzo, Aaron Wolfgang, Bryan Barksdale, et al.
American Journal of Psychiatry (2025) Vol. 182, Iss. 1, pp. 54-78
Closed Access | Times Cited: 1
Psychedelic Therapy's Transdiagnostic Effects: A Research Domain Criteria (RDoC) Perspective
John R. Kelly, Claire M. Gillan, Jack Prenderville, et al.
Frontiers in Psychiatry (2021) Vol. 12
Open Access | Times Cited: 51
LSD, afterglow and hangover: Increased episodic memory and verbal fluency, decreased cognitive flexibility
Isabel Wießner, Rodolfo Olivieri, Marcelo Falchi, et al.
European Neuropsychopharmacology (2022) Vol. 58, pp. 7-19
Closed Access | Times Cited: 32
Are psychedelic medicines the reset for chronic pain? Preliminary findings and research needs
Farah Zia, Michael H. Baumann, Sean J. Belouin, et al.
Neuropharmacology (2023) Vol. 233, pp. 109528-109528
Open Access | Times Cited: 20
Assessment of the Acute Effects of 2C‐B vs. Psilocybin on Subjective Experience, Mood, and Cognition
Pablo Mallaroni, Natasha L. Mason, Johannes T. Reckweg, et al.
Clinical Pharmacology & Therapeutics (2023) Vol. 114, Iss. 2, pp. 423-433
Open Access | Times Cited: 17
Do the therapeutic effects of psilocybin involve actions in the gut?
Felicia Reed, Claire J. Foldi
Trends in Pharmacological Sciences (2024) Vol. 45, Iss. 2, pp. 107-117
Closed Access | Times Cited: 6
Keeping the promise: a critique of the current state of microdosing research
Rotem Petranker, Thomas Anderson, Emily C. Fewster, et al.
Frontiers in Psychiatry (2024) Vol. 15
Open Access | Times Cited: 6
Protocols and practices in psilocybin assisted psychotherapy for depression: A systematic review
Noah Chisamore, Danica E. Johnson, Margery J.Q. Chen, et al.
Journal of Psychiatric Research (2024) Vol. 176, pp. 77-84
Closed Access | Times Cited: 6
Trajectory of Antidepressant Effects after Single- or Two-Dose Administration of Psilocybin: A Systematic Review and Multivariate Meta-Analysis
Chia‐Ling Yu, Chih‐Sung Liang, Fu‐Chi Yang, et al.
Journal of Clinical Medicine (2022) Vol. 11, Iss. 4, pp. 938-938
Open Access | Times Cited: 25
Psilocybin’s effects on cognition and creativity: A scoping review
Justin N Bonnieux, Baeleigh VanderZwaag, Zahra Premji, et al.
Journal of Psychopharmacology (2023) Vol. 37, Iss. 7, pp. 635-648
Open Access | Times Cited: 15
Minorities’ diminished psychedelic returns: Cardio-metabolic health
Sean Matthew Viña
Drug Science Policy and Law (2024) Vol. 10
Open Access | Times Cited: 5
Unraveling psilocybin’s therapeutic potential: behavioral and neuroplasticity insights in Wistar-Kyoto and Wistar male rat models of treatment-resistant depression
Magdalena Kolasa, Agnieszka Nikiforuk, Agata Korlatowicz, et al.
Psychopharmacology (2024)
Open Access | Times Cited: 5
Page 1 - Next Page

Scroll to top